Rating Change
TD Cowen analysts reiterated a Buy rating on Johnson & Johnson (NYSE:JNJ) on July 13, 2026.
reiterateNYSE:JNJ
TD Cowen Reiterates Buy Rating on Johnson & Johnson (JNJ)
Rating Change TD Cowen analysts reiterated a Buy rating on Johnson & Johnson (NYSE:JNJ) on July 13, 2026. Market Context Johnson & Johnson operates in the Healthcare sector. The…
Market Context
Johnson & Johnson operates in the Healthcare sector. The stock currently trades at $257.77 with a market capitalization of $505.8B. The stock has gained 38.2% over the past 52 weeks.
Analyst coverage from TD Cowen provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Johnson & Johnson.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Johnson & Johnson
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 13, 2026 | TD Cowen | Buy | N/A |
| Jul 13, 2026 | RBC Capital | Outperform | N/A |
| Jul 10, 2026 | B of A Securities | Neutral | N/A |
| Jul 08, 2026 | Citigroup | Buy | N/A |
| Jul 08, 2026 | Morgan Stanley | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View JNJ Stock Page
Frequently Asked Questions
What does a Buy rating mean for JNJ?
A Buy rating from TD Cowen reflects the analyst's outlook on Johnson & Johnson (NYSE:JNJ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the JNJ forecast page.
